Pharmaceutical Technology, December 2017 Issue (PDF)

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-12-02-2017
Volume 41
Issue 12

Click the title above to open the Pharmaceutical Technology December 2017 issue in an interactive PDF format.

External Link - PharmTech_NA_Dec2017.pdf

Articles in this issue
Disputes Over Manufacturing Waiver and Other SPC Exemptions
Opportunities with Softgels
Opportunities with Softgels
Bringing Together the Benefits of Lipid-Based Formulations and Modified-Release Drug Delivery
What’s in Your SOP?
Transformative Medicines Challenge FDA and Manufacturers
Pharma Outsourcing: A Year in Review
Outsourcing: A Year in Review
Designing Sustainable Pharma Facilities
Designing Sustainable Pharma Facilities
Evaluating Surface Cleanliness Using a Risk-Based Approach
Evaluating Surface Cleanliness Using a Risk-Based Approach
Formulating a Recipe for Bio/Pharma Career Success
Formulating a Recipe for Bio/Pharma Career Success
Wanted: A Highly Skilled Bio/Pharma Workforce
Hazardous Chemistry: Choosing Batch or Flow
Hazardous Chemistry: Choosing Batch or Flow
What are the Ingredients for Bio/Pharma Career Advancement?
What are the Ingredients for Bio/Pharma Career Advancement?
shutterstock_57398869_225.jpg
Critical Parameters in Transdermal Patch Manufacturing
Advances in Transdermal Patch Drug Delivery and Measurement
Recent Videos
Drug Digest: Patient Preference Drives Solid Dosage Trends
Behind the Headlines, Episode 17
Related Content
Teva Pharmaceuticals manufacturing site. Locally, Teva produces oral solid medicines and packaging. | Image Credit: © jetcityimage - stock.adobe.com

FDA Grants Fast Track Designation to Teva Celiac Disease Candidate

Patrick Lavery
May 30th 2025
Article

Teva’s investigational monoclonal antibody, TEV-53408, has been designed for use in adults with celiac disease, for which a strict and lifelong gluten-free diet is currently the only treatment.

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Patrick Lavery
May 30th 2025
Podcast

In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.

A lab technician in protective gear operates a tablet displaying a green checkmark in a high-tech pharmaceutical laboratory. | Image Credit: © greenbutterfly - stock.adobe.com

Companies Reveal Their Next Moves in Manufacturing

Patrick Lavery
May 29th 2025
Article

In discussions at INTERPHEX 2025, company representatives seized upon several common themes, most notably safety, sustainability, and the increasing utility of automation.

Site Logo

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Site Logo

End-to-end regulatory CDMO solutions: development, manufacturing, and approval (May 2025)

Lonza
May 29th 2025
Article

Site Logo

Exploring the need for dose-flexible manufacturing

Lonza
May 29th 2025
Article